Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...

Acquisition expected to strengthen Stryker's neurovascular business with Inari VTE product portfolio including mechanical ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Stryker Corporation has announced a definitive agreement to acquire all of the issued and outstanding shares of common stock ...

Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for ...

Fintel reports that on January 7, 2025, William Blair downgraded their outlook for Inari Medical (NasdaqGS:NARI) from ...

Irvine-based Inari Medical Inc. has entered into an agreement to be acquired for $4.9 billion by medical technology company ...

After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...

On the heels of rumors that have swirled over the past month, Stryker Corporation has officially announced a $4.9 billion acquisition of Inari Medical. The deal includes a tender offer for all ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

In a report released yesterday, William Plovanic from Canaccord Genuity downgraded Inari Medical (NARI – Research Report) to a Hold, with a ...